These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 23545424)
1. Small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model. Knowles JK; Simmons DA; Nguyen TV; Vander Griend L; Xie Y; Zhang H; Yang T; Pollak J; Chang T; Arancio O; Buckwalter MS; Wyss-Coray T; Massa SM; Longo FM Neurobiol Aging; 2013 Aug; 34(8):2052-63. PubMed ID: 23545424 [TBL] [Abstract][Full Text] [Related]
2. A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression. Simmons DA; Knowles JK; Belichenko NP; Banerjee G; Finkle C; Massa SM; Longo FM PLoS One; 2014; 9(8):e102136. PubMed ID: 25153701 [TBL] [Abstract][Full Text] [Related]
3. Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice. Nguyen TV; Shen L; Vander Griend L; Quach LN; Belichenko NP; Saw N; Yang T; Shamloo M; Wyss-Coray T; Massa SM; Longo FM J Alzheimers Dis; 2014; 42(2):459-83. PubMed ID: 24898660 [TBL] [Abstract][Full Text] [Related]
4. Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies. Yang T; Tran KC; Zeng AY; Massa SM; Longo FM Sci Rep; 2020 Nov; 10(1):20322. PubMed ID: 33230162 [TBL] [Abstract][Full Text] [Related]
5. The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo. Knowles JK; Rajadas J; Nguyen TV; Yang T; LeMieux MC; Vander Griend L; Ishikawa C; Massa SM; Wyss-Coray T; Longo FM J Neurosci; 2009 Aug; 29(34):10627-37. PubMed ID: 19710315 [TBL] [Abstract][Full Text] [Related]
6. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway. Elshaer SL; Alwhaibi A; Mohamed R; Lemtalsi T; Coucha M; Longo FM; El-Remessy AB Diabetologia; 2019 Aug; 62(8):1488-1500. PubMed ID: 31073629 [TBL] [Abstract][Full Text] [Related]
7. Modulation of the p75 neurotrophin receptor suppresses age-related basal forebrain cholinergic neuron degeneration. Xie Y; Meeker RB; Massa SM; Longo FM Sci Rep; 2019 Mar; 9(1):5273. PubMed ID: 30918278 [TBL] [Abstract][Full Text] [Related]
8. Acute administration of the small-molecule p75(NTR) ligand does not prevent hippocampal neuron loss or development of spontaneous seizures after pilocarpine-induced status epilepticus. Grabenstatter HL; Carlsen J; Raol YH; Yang T; Hund D; Cruz Del Angel Y; White AM; Gonzalez MI; Longo FM; Russek SJ; Brooks-Kayal AR J Neurosci Res; 2014 Oct; 92(10):1307-18. PubMed ID: 24801281 [TBL] [Abstract][Full Text] [Related]
9. Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery. Nguyen TV; Crumpacker RH; Calderon KE; Garcia FG; Zbesko JC; Frye JB; Gonzalez S; Becktel DA; Yang T; Tavera-Garcia MA; Morrison HW; Schnellmann RG; Longo FM; Doyle KP J Pharmacol Exp Ther; 2022 Feb; 380(2):126-141. PubMed ID: 34893553 [TBL] [Abstract][Full Text] [Related]
10. Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage. Gonzalez S; McHugh TLM; Yang T; Syriani W; Massa SM; Longo FM; Simmons DA Neurobiol Dis; 2022 Jan; 162():105563. PubMed ID: 34838668 [TBL] [Abstract][Full Text] [Related]
11. Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75 Simmons DA; Mills BD; Butler Iii RR; Kuan J; McHugh TLM; Akers C; Zhou J; Syriani W; Grouban M; Zeineh M; Longo FM Neurotherapeutics; 2021 Apr; 18(2):1039-1063. PubMed ID: 33786806 [TBL] [Abstract][Full Text] [Related]
12. Small molecule modulation of the p75 neurotrophin receptor suppresses age- and genotype-associated neurodegeneration in HIV gp120 transgenic mice. Xie Y; Seawell J; Boesch E; Allen L; Suchy A; Longo FM; Meeker RB Exp Neurol; 2021 Jan; 335():113489. PubMed ID: 33007293 [TBL] [Abstract][Full Text] [Related]
13. Oral Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Improves Erectile Function in a Mouse Model of Cavernous Nerve Injury. Yin GN; Ock J; Limanjaya A; Minh NN; Hong SS; Yang T; Longo FM; Ryu JK; Suh JK J Sex Med; 2021 Jan; 18(1):17-28. PubMed ID: 33243690 [TBL] [Abstract][Full Text] [Related]
14. Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR. Friesland A; Weng Z; Duenas M; Massa SM; Longo FM; Lu Q Neurotoxicology; 2014 Dec; 45():81-90. PubMed ID: 25277379 [TBL] [Abstract][Full Text] [Related]
15. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589 [TBL] [Abstract][Full Text] [Related]
16. A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice. Simmons DA; Belichenko NP; Ford EC; Semaan S; Monbureau M; Aiyaswamy S; Holman CM; Condon C; Shamloo M; Massa SM; Longo FM Hum Mol Genet; 2016 Nov; 25(22):4920-4938. PubMed ID: 28171570 [TBL] [Abstract][Full Text] [Related]
17. Selective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interaction. Fombonne J; Rabizadeh S; Banwait S; Mehlen P; Bredesen DE Ann Neurol; 2009 Mar; 65(3):294-303. PubMed ID: 19334058 [TBL] [Abstract][Full Text] [Related]
18. A small molecule p75(NTR) ligand protects neurogenesis after traumatic brain injury. Shi J; Longo FM; Massa SM Stem Cells; 2013 Nov; 31(11):2561-74. PubMed ID: 23940017 [TBL] [Abstract][Full Text] [Related]
19. Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairment. Yang T; Knowles JK; Lu Q; Zhang H; Arancio O; Moore LA; Chang T; Wang Q; Andreasson K; Rajadas J; Fuller GG; Xie Y; Massa SM; Longo FM PLoS One; 2008; 3(11):e3604. PubMed ID: 18978948 [TBL] [Abstract][Full Text] [Related]
20. p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Shanks HRC; Chen K; Reiman EM; Blennow K; Cummings JL; Massa SM; Longo FM; Börjesson-Hanson A; Windisch M; Schmitz TW Nat Med; 2024 Jun; 30(6):1761-1770. PubMed ID: 38760589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]